日均上千人在这家医院接受免陪照护，上海医卫发展如何与民生“同频”

Core Insights - The Shanghai government work report for 2026 emphasizes the acceleration of building a "no-companion care service system" and the deepening of multi-dimensional medical insurance payment reforms, along with the promotion of innovative drugs and medical devices [1][3] Group 1: No-Companion Care Service - The "no-companion care service" aims to alleviate the burden on only children as the aging population increases, with an average of 1,300 to 1,400 patients receiving this service daily at Zhongshan Hospital [1][3] - There is a significant shortage of skilled nursing personnel for this service, with concerns about their education level and fragmented labor relations [1][5] - Recommendations include professional training for caregivers and establishing comprehensive fee standards for various levels of care, from basic to advanced [5][6] Group 2: AI in Healthcare - The application of AI in clinical settings is a growing focus, with suggestions for organized development to avoid redundant efforts and enhance the training of specialized models [7] - The need for authoritative and market-validated AI models is highlighted, emphasizing the importance of data quality and professional expertise [7] Group 3: Innovation in Biomedicine - The biomedicine sector faces challenges in innovation, requiring collaboration among scientists, clinical experts, and international organizations to enhance technology transfer and application [8][9] - The establishment of a "data factory" model is proposed to overcome data barriers and support drug development, with government-led initiatives to create a public platform for data integration [9][10] Group 4: Regulatory and Market Access - Suggestions include creating a "zero time difference" access channel for innovative drugs and medical devices in Shanghai, allowing for expedited approval processes for urgently needed products [10][11] - The exploration of cross-border data flow in healthcare is recommended to support international collaboration and digital therapy products [11]